Related Experiment Videos
Cyclins and cell cycle checkpoints
1M.D. Anderson Cancer Center, Smithville, Texas 78957, USA.
Abstract:
The eucaryotic cell cycle is regulated by the periodic synthesis and destruction of cyclins that associate with and activate cyclin-dependent kinases. Cyclin-dependent kinase inhibitors, such as p21 and p16, also play important roles in cell cycle control by coordinating internal and external signals and impeding proliferation at several key checkpoints. Understanding how these proteins interact to regulate the cell cycle has become increasingly important to researchers and clinicians with the discovery that many of the genes that encode cell cycle regulatory activities are targets for alterations that underlie the development of cancer. Several therapeutic agents, such as DNA-damaging drugs, microtubule inhibitors, antimetabolites, and topoisomerase inhibitors, take advantage of this disruption in normal cell cycle regulation to target checkpoint controls and ultimately induce growth arrest or apoptosis of neoplastic cells. Other therapeutic drugs being developed, such as UCN-01, specifically inhibit cell cycle regulatory proteins.
Insights
The cell cycle is controlled by cyclins and cyclin-dependent kinases, with inhibitors like p21 and p16 crucial for preventing cancer. Therapeutic drugs target these cell cycle regulators to treat cancer by inducing cell death.
Area of Science:
- Cell Biology
- Cancer Research
- Pharmacology
Background:
- The eukaryotic cell cycle is governed by cyclins and cyclin-dependent kinases.
- Cell cycle inhibitors (e.g., p21, p16) are vital for checkpoint control and signal coordination.
- Dysregulation of cell cycle genes is implicated in cancer development.
Purpose of the Study:
- To explore the regulatory mechanisms of the cell cycle.
- To understand the role of cell cycle proteins in cancer.
- To review therapeutic strategies targeting cell cycle regulation in cancer treatment.
Main Methods:
- Review of existing literature on cell cycle regulation.
- Analysis of the role of cyclins, cyclin-dependent kinases, and inhibitors.
- Examination of therapeutic agents targeting cell cycle checkpoints.
Main Results:
- Cyclins and cyclin-dependent kinases drive cell cycle progression.
- Inhibitors like p21 and p16 act as critical checkpoints.
- Cancer often involves alterations in cell cycle regulatory genes.
Conclusions:
- Understanding cell cycle regulation is key to cancer research and treatment.
- Therapeutic agents exploit cell cycle disruptions to induce cancer cell apoptosis.
- Targeted drugs like UCN-01 show promise in inhibiting cell cycle proteins.